세계의 안티에이징 의약품 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Anti-aging Drugs was estimated to be worth US$ 11030 million in 2024 and is forecast to a readjusted size of US$ 23970 million by 2031 with a CAGR of 11.9% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Anti-aging Drugs cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.

The anti-aging drugs market is propelled by several compelling factors. Most notably, the global population is aging rapidly-by 2050, the number of people aged 65 and above is projected to reach around 1.5-2.1 billion. This demographic shift fuels demand for therapies targeting age-related diseases like cardiovascular disorders, diabetes, neurodegenerative conditions, osteoporosis, and skin photoaging . Meanwhile, breakthroughs in biotechnology-spanning CRISPR, senolytics, mTOR inhibitors, NAD+ boosters, regenerative medicine, gene-editing, and AI-enabled drug discovery-are unlocking new therapeutic avenues. Rising disposable incomes, especially in emerging markets, and heightened consumer demand for wellness and aesthetic solutions further support market expansion.

Nevertheless, the sector faces significant hurdles. Chief among them are the exorbitant research and R&D costs-developing these drugs typically involves multi-year investment, expensive clinical trials, and complex regulatory approval procedures, often costing upwards of $1 billion . Regulatory ambiguity is another barrier: aging is not formally recognized as a disease, and oversight for aging-related therapies remains unclear, delaying approvals . Limited clinical evidence, short-term trial data, and safety concerns (e.g., off-label use, side effects, lack of biomarkers) hinder adoption

This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-aging Drugs by region & country, by Type, and by Application.

The Anti-aging Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs.

Market Segmentation

By Company

• AbbVie
• Galderma
• LG Life Sciences
• Merz
• Medytox
• Hugel
• Croma-Pharma
• Beijing IMEIK
• Bloomage Bio
• Elravie (Humedix)
• Cleviel (Pharma Research Products)
• Haohai Biological
• Teoxane
• Sinclair
• Suneva Medical
• CG Bio
• SciVision Biotech
• Prollenium
• Bohus BioTech
• Caregen
• Ipsen
• LIBP
• US World Meds
• Daewoong
• JETEMA

Segment by Type

• Dermal Fillers
• Botulinum Toxin
• Others

Segment by Application

• Hospital
• Beauty Parlor
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Anti-aging Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Anti-aging Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Anti-aging Drugs Product Introduction
• 1.2 Global Anti-aging Drugs Market Size Forecast
  • 1.2.1 Global Anti-aging Drugs Sales Value (2020-2031)
  • 1.2.2 Global Anti-aging Drugs Sales Volume (2020-2031)
  • 1.2.3 Global Anti-aging Drugs Sales Price (2020-2031)
• 1.3 Anti-aging Drugs Market Trends & Drivers
  • 1.3.1 Anti-aging Drugs Industry Trends
  • 1.3.2 Anti-aging Drugs Market Drivers & Opportunity
  • 1.3.3 Anti-aging Drugs Market Challenges
  • 1.3.4 Anti-aging Drugs Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Anti-aging Drugs Players Revenue Ranking (2024)
• 2.2 Global Anti-aging Drugs Revenue by Company (2020-2025)
• 2.3 Global Anti-aging Drugs Players Sales Volume Ranking (2024)
• 2.4 Global Anti-aging Drugs Sales Volume by Company Players (2020-2025)
• 2.5 Global Anti-aging Drugs Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Anti-aging Drugs Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Anti-aging Drugs Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Anti-aging Drugs
• 2.9 Anti-aging Drugs Market Competitive Analysis
  • 2.9.1 Anti-aging Drugs Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Anti-aging Drugs Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging Drugs as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Dermal Fillers
  • 3.1.2 Botulinum Toxin
  • 3.1.3 Others
• 3.2 Global Anti-aging Drugs Sales Value by Type
  • 3.2.1 Global Anti-aging Drugs Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Anti-aging Drugs Sales Value, by Type (2020-2031)
  • 3.2.3 Global Anti-aging Drugs Sales Value, by Type (%) (2020-2031)
• 3.3 Global Anti-aging Drugs Sales Volume by Type
  • 3.3.1 Global Anti-aging Drugs Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Anti-aging Drugs Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Anti-aging Drugs Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Anti-aging Drugs Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospital
  • 4.1.2 Beauty Parlor
  • 4.1.3 Others
• 4.2 Global Anti-aging Drugs Sales Value by Application
  • 4.2.1 Global Anti-aging Drugs Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Anti-aging Drugs Sales Value, by Application (2020-2031)
  • 4.2.3 Global Anti-aging Drugs Sales Value, by Application (%) (2020-2031)
• 4.3 Global Anti-aging Drugs Sales Volume by Application
  • 4.3.1 Global Anti-aging Drugs Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Anti-aging Drugs Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Anti-aging Drugs Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Anti-aging Drugs Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Anti-aging Drugs Sales Value by Region
  • 5.1.1 Global Anti-aging Drugs Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Anti-aging Drugs Sales Value by Region (2020-2025)
  • 5.1.3 Global Anti-aging Drugs Sales Value by Region (2026-2031)
  • 5.1.4 Global Anti-aging Drugs Sales Value by Region (%), (2020-2031)
• 5.2 Global Anti-aging Drugs Sales Volume by Region
  • 5.2.1 Global Anti-aging Drugs Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Anti-aging Drugs Sales Volume by Region (2020-2025)
  • 5.2.3 Global Anti-aging Drugs Sales Volume by Region (2026-2031)
  • 5.2.4 Global Anti-aging Drugs Sales Volume by Region (%), (2020-2031)
• 5.3 Global Anti-aging Drugs Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Anti-aging Drugs Sales Value, 2020-2031
  • 5.4.2 North America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Anti-aging Drugs Sales Value, 2020-2031
  • 5.5.2 Europe Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Anti-aging Drugs Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Anti-aging Drugs Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Anti-aging Drugs Sales Value, 2020-2031
  • 5.7.2 South America Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Anti-aging Drugs Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Anti-aging Drugs Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Anti-aging Drugs Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Anti-aging Drugs Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Anti-aging Drugs Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Anti-aging Drugs Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Anti-aging Drugs Sales Value, 2020-2031
  • 6.3.2 United States Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Anti-aging Drugs Sales Value, 2020-2031
  • 6.4.2 Europe Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Anti-aging Drugs Sales Value, 2020-2031
  • 6.5.2 China Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Anti-aging Drugs Sales Value, 2020-2031
  • 6.6.2 Japan Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Anti-aging Drugs Sales Value, 2020-2031
  • 6.7.2 South Korea Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Anti-aging Drugs Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Anti-aging Drugs Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Anti-aging Drugs Sales Value, 2020-2031
  • 6.9.2 India Anti-aging Drugs Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Anti-aging Drugs Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 AbbVie
  • 7.1.1 AbbVie Company Information
  • 7.1.2 AbbVie Introduction and Business Overview
  • 7.1.3 AbbVie Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 AbbVie Anti-aging Drugs Product Offerings
  • 7.1.5 AbbVie Recent Development
• 7.2 Galderma
  • 7.2.1 Galderma Company Information
  • 7.2.2 Galderma Introduction and Business Overview
  • 7.2.3 Galderma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Galderma Anti-aging Drugs Product Offerings
  • 7.2.5 Galderma Recent Development
• 7.3 LG Life Sciences
  • 7.3.1 LG Life Sciences Company Information
  • 7.3.2 LG Life Sciences Introduction and Business Overview
  • 7.3.3 LG Life Sciences Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 LG Life Sciences Anti-aging Drugs Product Offerings
  • 7.3.5 LG Life Sciences Recent Development
• 7.4 Merz
  • 7.4.1 Merz Company Information
  • 7.4.2 Merz Introduction and Business Overview
  • 7.4.3 Merz Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Merz Anti-aging Drugs Product Offerings
  • 7.4.5 Merz Recent Development
• 7.5 Medytox
  • 7.5.1 Medytox Company Information
  • 7.5.2 Medytox Introduction and Business Overview
  • 7.5.3 Medytox Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Medytox Anti-aging Drugs Product Offerings
  • 7.5.5 Medytox Recent Development
• 7.6 Hugel
  • 7.6.1 Hugel Company Information
  • 7.6.2 Hugel Introduction and Business Overview
  • 7.6.3 Hugel Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Hugel Anti-aging Drugs Product Offerings
  • 7.6.5 Hugel Recent Development
• 7.7 Croma-Pharma
  • 7.7.1 Croma-Pharma Company Information
  • 7.7.2 Croma-Pharma Introduction and Business Overview
  • 7.7.3 Croma-Pharma Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Croma-Pharma Anti-aging Drugs Product Offerings
  • 7.7.5 Croma-Pharma Recent Development
• 7.8 Beijing IMEIK
  • 7.8.1 Beijing IMEIK Company Information
  • 7.8.2 Beijing IMEIK Introduction and Business Overview
  • 7.8.3 Beijing IMEIK Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Beijing IMEIK Anti-aging Drugs Product Offerings
  • 7.8.5 Beijing IMEIK Recent Development
• 7.9 Bloomage Bio
  • 7.9.1 Bloomage Bio Company Information
  • 7.9.2 Bloomage Bio Introduction and Business Overview
  • 7.9.3 Bloomage Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Bloomage Bio Anti-aging Drugs Product Offerings
  • 7.9.5 Bloomage Bio Recent Development
• 7.10 Elravie (Humedix)
  • 7.10.1 Elravie (Humedix) Company Information
  • 7.10.2 Elravie (Humedix) Introduction and Business Overview
  • 7.10.3 Elravie (Humedix) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Elravie (Humedix) Anti-aging Drugs Product Offerings
  • 7.10.5 Elravie (Humedix) Recent Development
• 7.11 Cleviel (Pharma Research Products)
  • 7.11.1 Cleviel (Pharma Research Products) Company Information
  • 7.11.2 Cleviel (Pharma Research Products) Introduction and Business Overview
  • 7.11.3 Cleviel (Pharma Research Products) Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Cleviel (Pharma Research Products) Anti-aging Drugs Product Offerings
  • 7.11.5 Cleviel (Pharma Research Products) Recent Development
• 7.12 Haohai Biological
  • 7.12.1 Haohai Biological Company Information
  • 7.12.2 Haohai Biological Introduction and Business Overview
  • 7.12.3 Haohai Biological Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Haohai Biological Anti-aging Drugs Product Offerings
  • 7.12.5 Haohai Biological Recent Development
• 7.13 Teoxane
  • 7.13.1 Teoxane Company Information
  • 7.13.2 Teoxane Introduction and Business Overview
  • 7.13.3 Teoxane Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Teoxane Anti-aging Drugs Product Offerings
  • 7.13.5 Teoxane Recent Development
• 7.14 Sinclair
  • 7.14.1 Sinclair Company Information
  • 7.14.2 Sinclair Introduction and Business Overview
  • 7.14.3 Sinclair Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Sinclair Anti-aging Drugs Product Offerings
  • 7.14.5 Sinclair Recent Development
• 7.15 Suneva Medical
  • 7.15.1 Suneva Medical Company Information
  • 7.15.2 Suneva Medical Introduction and Business Overview
  • 7.15.3 Suneva Medical Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Suneva Medical Anti-aging Drugs Product Offerings
  • 7.15.5 Suneva Medical Recent Development
• 7.16 CG Bio
  • 7.16.1 CG Bio Company Information
  • 7.16.2 CG Bio Introduction and Business Overview
  • 7.16.3 CG Bio Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.16.4 CG Bio Anti-aging Drugs Product Offerings
  • 7.16.5 CG Bio Recent Development
• 7.17 SciVision Biotech
  • 7.17.1 SciVision Biotech Company Information
  • 7.17.2 SciVision Biotech Introduction and Business Overview
  • 7.17.3 SciVision Biotech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.17.4 SciVision Biotech Anti-aging Drugs Product Offerings
  • 7.17.5 SciVision Biotech Recent Development
• 7.18 Prollenium
  • 7.18.1 Prollenium Company Information
  • 7.18.2 Prollenium Introduction and Business Overview
  • 7.18.3 Prollenium Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.18.4 Prollenium Anti-aging Drugs Product Offerings
  • 7.18.5 Prollenium Recent Development
• 7.19 Bohus BioTech
  • 7.19.1 Bohus BioTech Company Information
  • 7.19.2 Bohus BioTech Introduction and Business Overview
  • 7.19.3 Bohus BioTech Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.19.4 Bohus BioTech Anti-aging Drugs Product Offerings
  • 7.19.5 Bohus BioTech Recent Development
• 7.20 Caregen
  • 7.20.1 Caregen Company Information
  • 7.20.2 Caregen Introduction and Business Overview
  • 7.20.3 Caregen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.20.4 Caregen Anti-aging Drugs Product Offerings
  • 7.20.5 Caregen Recent Development
• 7.21 Ipsen
  • 7.21.1 Ipsen Company Information
  • 7.21.2 Ipsen Introduction and Business Overview
  • 7.21.3 Ipsen Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.21.4 Ipsen Anti-aging Drugs Product Offerings
  • 7.21.5 Ipsen Recent Development
• 7.22 LIBP
  • 7.22.1 LIBP Company Information
  • 7.22.2 LIBP Introduction and Business Overview
  • 7.22.3 LIBP Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.22.4 LIBP Anti-aging Drugs Product Offerings
  • 7.22.5 LIBP Recent Development
• 7.23 US World Meds
  • 7.23.1 US World Meds Company Information
  • 7.23.2 US World Meds Introduction and Business Overview
  • 7.23.3 US World Meds Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.23.4 US World Meds Anti-aging Drugs Product Offerings
  • 7.23.5 US World Meds Recent Development
• 7.24 Daewoong
  • 7.24.1 Daewoong Company Information
  • 7.24.2 Daewoong Introduction and Business Overview
  • 7.24.3 Daewoong Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.24.4 Daewoong Anti-aging Drugs Product Offerings
  • 7.24.5 Daewoong Recent Development
• 7.25 JETEMA
  • 7.25.1 JETEMA Company Information
  • 7.25.2 JETEMA Introduction and Business Overview
  • 7.25.3 JETEMA Anti-aging Drugs Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.25.4 JETEMA Anti-aging Drugs Product Offerings
  • 7.25.5 JETEMA Recent Development

8 Industry Chain Analysis

• 8.1 Anti-aging Drugs Industrial Chain
• 8.2 Anti-aging Drugs Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Anti-aging Drugs Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Anti-aging Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer